GSA Capital Partners’s Zentalis Pharmaceuticals ZNTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.32M | Buy |
1,133,375
+591,400
| +109% | +$686K | 0.09% | 296 |
|
|
2025
Q1 | $862K | Buy |
541,975
+397,805
| +276% | +$633K | 0.08% | 438 |
|
|
2024
Q4 | $437K | Sell |
144,170
-464,415
| -76% | -$1.41M | 0.03% | 985 |
|
|
2024
Q3 | $2.24M | Buy |
608,585
+353,384
| +138% | +$1.3M | 0.17% | 91 |
|
|
2024
Q2 | $1.04M | Buy |
255,201
+244,599
| +2,307% | +$1M | 0.07% | 475 |
|
|
2024
Q1 | $167K | Buy |
+10,602
| New | +$167K | 0.01% | 1434 |
|
|
2023
Q4 | – | Sell |
-24,344
| Closed | -$488K | – | 2000 |
|
|
2023
Q3 | $488K | Buy |
+24,344
| New | +$488K | 0.04% | 818 |
|
|
2022
Q2 | – | Sell |
-12,979
| Closed | -$599K | – | 1867 |
|
|
2022
Q1 | $599K | Sell |
12,979
-13,885
| -52% | -$641K | 0.08% | 423 |
|
|
2021
Q4 | $2.26M | Buy |
+26,864
| New | +$2.26M | 0.28% | 13 |
|